D

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Senior Director, Medical Affairs Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA$265k - $300k

About the Job

Requirements

  • A PhD in Statistics, Biostatistics, or a related quantitative discipline with at least 10 years of relevant pharmaceutical, biotechnology, or health-related industry experience, or an MS with at least 12 years of relevant experience.
  • Demonstrated experience leading the design, analysis, interpretation, and reporting of Medical Affairs analyses, including Phase IV, observational, registry, and real-world evidence studies.
  • Experience supporting scientific publications, congress presentations, investigator-sponsored research, and external scientific engagement, including collaboration with investigators and presentation of statistical findings.
  • Strong expertise in statistical methodology relevant to observational and real-world research, including study design, bias and confounding, causal inference, longitudinal analysis, missing data, endpoint strategy, and time-to-event methods.
  • Advanced SAS programming skills and the ability to perform, review, and oversee statistical analyses.
  • Experience overseeing CROs, consultants, and external vendors, including scope management, quality oversight, timelines, and deliverables.
  • Demonstrated experience leading and developing statisticians through direct management, matrix leadership, technical mentorship, or functional capability-building.
  • Ability to independently prioritize and manage multiple concurrent priorities and deliverables in a fast-paced, matrixed biotechnology environment.
  • Strong analytical judgment and problem-solving skills, with the ability to work through ambiguity, anticipate risks, and recommend practical, scientifically sound solutions.
  • Ability to effectively communicate complex statistical concepts to technical and non-technical audiences, including senior leaders and external stakeholders.
  • Interest in and basic understanding of biology and biological processes, including ASO and siRNA modalities.

Responsibilities

  • Serve as the senior Biostatistics lead and subject matter expert for Medical Affairs, providing strategic direction, independent statistical judgment, and hands-on statistical leadership.
  • Shape integrated evidence-generation strategies and product-level evidence plans in partnership with Medical Affairs, Clinical Development, HEOR, Value & Access, Regulatory, and Commercial stakeholders.
  • Represent Biostatistics on cross-functional Medical Affairs and evidence-generation teams, influencing strategic decisions and ensuring statistical approaches are scientifically rigorous, practical, and aligned with business and patient needs.
  • Lead statistical strategy, study design, methodology, and execution for Phase IV, observational, registry, and real-world evidence studies.
  • Lead secondary, exploratory, and post hoc analyses of clinical development data to support Medical Affairs strategy, scientific exchange, publications, congress presentations, payer evidence, and lifecycle planning.
  • Provide statistical expertise to HEOR, Value & Access, HTA, and payer-related activities, including methods for evidence generation, interpretation, and communication to external stakeholders.
  • Provide statistical leadership for clinical outcomes assessment, including PRO/HRQoL analysis, psychometric evaluation, score derivation, endpoint interpretation, and evidence to support publications, payer dossiers, and potential label-enabling activities.
  • Lead the statistical strategy for Medical Affairs publications and scientific communications, including manuscripts, abstracts, congress presentations, advisory boards, investigator-sponsored research, and external scientific collaborations.
  • Partner with Clinical Development Biostatistics to leverage complementary expertise, ensure consistency across the product lifecycle, and maintain alignment between development, regulatory, and Medical Affairs analyses.
  • Analyze, interpret, and communicate complex results to cross-functional teams, senior leadership, external collaborators, and non-technical audiences in a clear and actionable manner.
  • Develop, review, and execute analysis plans, supplemental statistical analysis plans, table/listing/figure shells, dataset specifications, and associated documentation to ensure high-quality, inspection-ready statistical deliverables.
  • Partner with Data Management, Statistical Programming, Clinical Operations, and external vendors to ensure fit-for-purpose data, efficient study execution, and high-quality, timely statistical deliverables supporting Medical Affairs studies and evidence-generation initiatives.
  • Provide oversight of CROs, consultants, and external vendors, including scope, quality, timelines, resourcing, issue escalation, and delivery of statistical services.
  • Drive standardization, process improvement, templates, best practices, and functional standards within Biostatistics and across cross-functional teams.
  • Manage, mentor, and develop direct reports and other statistical colleagues through direct management, matrix leadership, and technical mentorship, fostering technical excellence, collaboration, accountability, and a high-performing team environment.

Desired Qualifications

  • Experience with R and familiarity with contemporary tools and approaches for real-world data analysis.
  • Experience in rare disease drug development, preferably neuromuscular disease.

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs